Life Sciences company Quanterix Corp. on Monday launched its initial public offering, and said it will offer 3.34 million shares priced at $14 to $16 a pop. The company would raise $50.1 million at the midpoint of the price range. The company is planning to list on Nasdaq, under the ticker symbol ‘QTRX’. J.P. Morgan, Leerink Partners and Cowen are joint bookrunners on the deal with BTIG and Evercore ISI acting as co-managers. Proceeds of the deal will be used to expand the company’s commercial operations, improve and update its Simoa technology, support a 2018 product launch, move to a larger corporate headquarters, pursue regulatory approval to develop certain instruments, to pursue acquisitions and for general corporate purposes.
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
From:: Stock Market News